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Abstract
Background. One of characteristics in Diabetes diet is giving food with high complex carbohydrate, 
particularly fi ber.  Th e benefi t of resistant starch fi ber include maintaning blood glucose and increasing the 
insulin sensitifi ty. 
Aims. Th is study aimed to fi nd the eff ect of providing food made from resistant starch fi ber (Dioscorea 
esculenta, Maranta arundinaceae L, Cucurbita moschata, Manihot utilissma) on the improvement of blood 
glucose control in diabetes patients based on glycated albumin test. 
Methods. Th e Quasi-experimental study was used in diabetes type-2 patients who visited endocrinology 
polyclinic at Dr Sardjito Hospital, during 1 November 2015-31 January 2016. Food made from resistant 
starch fi ber was served as a daily snack for one month. Blood glycated albumin was examined before and 
after food providence. SPSS was used for statistical analyses. 
Results.  We recruited 17 subjects in the control group and 17 subjects in the treatment group. In the control 
group, the index of albumin was signifi cantly deteriorated from 15.1% to 18.13%. In the treatment group, 
the index of albumin was reduced from 29.71% to 18.73% showing an improvement of 10.97% (p= 0.01).
Conclusion. Th ere was a signifi cantly improvement of blood glycated albumin (10.97%) after consuming 
food that was made from resistant of starch fi ber (p=0.01). 
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Abstrak
Latar Belakang. Salah satu ciri khas dari diet Diabetes Melitus (DM) tipe 2 adalah pemberian  makanan 
tinggi karbohidrat kompleks terutama serat. Diet pati resisten berfungsi untuk mengatur agar glukosa darah tidak 
meningkat secara signifi kan dan meningkatkan sensitivitas insulin pada DM. 
Tujuan Penelitian. Mengetahui pengaruh pemberian makanan berbahan dasar serat pati resisten (Dioscorea 
esculenta, Maranta arundinaceae L, Cucurbita moschata, Manihot utilissma) terhadap perbaikan kendali glukosa 
darah pasien Diabetes Mellitus tipe 2 berdasarkan pemeriksaan albumin terglikasi.
Metode. Uji Kuasi Experimental pada pasien DM tipe 2 Obes yang kontrol di poli endokrin RSUP Dr. Sardjito, 
selama tanggal 1 November 2015-31 Januari 2016. Subyek diberikan konsumsi makanan dalam bentuk makanan 
ringan berbahan dasar serat pati resisten selama 1 bulan, dan di hitung albumin terglikasi sebelum dan setelah 
perlakuan dan dibandingkan dengan kelompok kontrol. Hasil diuji dengan SPSS untuk mencari perbedaan rerata.
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Introduction 
Diabetes Mellitus (DM) is a chronic 
disease. World Health Organization (WHO) 
predicts the increase of frequency of diabetes 
patients in Indonesia from 8.4 million in 2000 
to 21.3 million in 2030.1
Management in DM consists  of 
education, lifestyle modification, physical 
exercise, diet modifi cation and pharmacology 
treatment.1 One particular diet in DM type 2 
is carbohydrate complex, high fi ber and low 
simple carbohydrate. Resistant Starch fi ber can 
control the blood glucose because it is slowly 
digested, slower transit time and improve the 
insulin sensitivity.2
Resistant Starch Fiber has high viscosity 
and can block glucose absorbtion, thus it will 
decrease blood glucose.3,4 Resistant starch fi ber 
is fermented in colon because of microfl ora and 
produces short chain fatty acid such as acetate, 
propionate and butyrate which improve 
insulin sensitivity.3,5,6 Some of roots have a 
fi ber resistant starch fi ber compotition such as 
gembili (Dioscorea esculenta), garut (Maranta 
arundinacea), kimpul and gadung.7 Th e result 
of study in diabetes experimental Wistar mouse 
shows a signifi cant blood glucose decrease in a 
group provided with gembili as a diet.8 
One of an accurate long biomarker of 
glycemic control is glycated albumin. Th is test 
can show glycemic control within 2-4 weeks 
before.9
Th is study aimed to give evidence about 
the good eff ect of providing food containing 
resistant starch fiber to improve glycemic 
control in diabetes type 2 patients based on 
glycated albumin test. 
Methods
This study was Quasi Experimentally 
designed. Th is study was one of a part in the 
study by dr. Sunarti, M.Kes titled “Th erapy of 
food based on Gembili as antidyslipidemia and 
antihyperglicemia in Diabetes Mellitus type 
2 subject” with ethical clearance number KE/
FK/1073/EC (28 August 2015). 
Th e study was done in Endocrinology 
clinic, Department of Internal Medicine, Dr. 
Sardjito General Hospital Yogyakarta during 1 
November 2015 until 31 January 2016. Study 
subject were hospital employees with diabetes 
and obesity. Th ey were patients with type 2 
diabetes, obesity with body mass index > 23.5 
kg/m2, regularly used willing to participate in 
the study. 
Exclusion criteria for this study included 
alcohol consumption, pregnancy, have severe 
infection, with renal inufi ciency (creatinine 
>1.5 mg/dl), hypoalbuminemia, proteinuria 
Hasil Penelitian. Sebanyak 17 subyek dalam kelompok kontrol dan 17 subyek dalam kelompok perlakuan 
dianalisis. Pada kelompok kontrol, indeks albumin terglikasi mengalami perburukan dari 15,1 % menjadi 18,13 
%. Sebaliknya pada kelompok perlakuan, indeks albumin terglikasi menurun dari 29,71 % menjadi 18,73 % 
atau terdapat perbaikan sebesar 10,97% (p=0,01).  
Kesimpulan. Terdapat perbaikan kadar albumin terglikasi secara klinis dan statistik sebesar 10,97% pada 
kelompok yang mendapatkan makanan berbahan dasar serat pati resisten bila dibandingkan dengan kelompok 
yang tidak mendapatkan diet serat pati resisten (p=0,01).
Kata Kunci: Diabetes type 2, makanan serat pati resisten, Albumin terglikasi
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>3.5 gr/day, hipertiroidism, malnutrition, 
hypotiroidism, chonic heart failure, icteric, 
liver cirrhosis, drink anorectic, steroid drugs, 
and the use sulfonylurea, acarbose, DPP IV 
Inhibitor, and GLP1 agonist.
Th e subjects was given food in a form of 
32 gram snack for a month, consisting of fi ber 
resistant starch fi ber from gembili (Dioscorea 
esculenta), garut  (Maranta arundinaceae 
L), labu kuning (Cucurbita moschata), and 
singkong  (Manihot utilissma)  with total 
calories 144.55 and resistant starch of 14.91%. 
Subject was educated about diet in diabetes. 
Calory counting was done every day by 
telephone interview and home visit by diabetic 
nutritionist. Glycated albumin were checked 
before and after one month.
Univariat analysis was done for each 
variable, distribution and characteristic of 
subject. Data was analyzed using SPSS and 
presented as means ± standar deviation. 
Normality data test continue used Saphiro-
Wilk. Mann Whitney test was used to analyze 
and compare the means of glycated albumin 
in both groups. Unpaired t-test was used if 
the data was normally distibuted and Mann 
Whitney if the data not normally distibuted. 
Signifi cant level of this study was p < 0.05. 
Th is study has been approved by ethical 
comitte of biomedical Faculty of Medicine 
Gadjah Mada University and permitted by 
the Director of Dr. Sardjito General Hospital 
Yogyakarta. Each subject provided a concent 
to participate.
Result
Th is study included 17-control subject 
and 17 subjects who received food based on 
resistant starch fi ber. Baseline characteristic is 
showed in table 1.  
Mean of age in the control group was 
53.82 years and in experimental group 54.12 
years. Male ini control group was 47.1% 
compared to 41.2% in experimental group. 
Body mass index control group was 28.64 kg/
m2 and experiment group was 28.5 kg/m2.
Table 2 showed a rise of body mass index 
from 28.64 kg/m2 to 28.69 kg/m2 in control 
group and 28.5 kg/m2 to 28.54 kg/m2 in 
experimental group, but the diff erences were 
not statistically signifi cant. In control group, 
glycated albumin increased from 15.1% to 
18.13 %. In the experimental group, glycated 
albumin improved from 29.71 % (fail control) 
to 18.73 % (good control). 
From table 2 we got the delta albumin 
in the group that did not get additional food-
based resistant starch fi ber was increased about 
3.02 ± 7.13% glycated albumin, and in the 
group which got additional food-based fi ber 
resistant starch fiber have improvement of 
glycated albumin equal to 10.97 ± 14.6% (p 
= 0.01).
In control group, failed subjects (17.6%) 
increased from 3 to 5 subjects (29.4%) and good 
test decreased from 13 subjects (76.5%) to 12 
subjects (70.6%). In experimental group very 
good response improved from 8 subjects (47.1%) 
to 11 subjects *64.7%) and in fail group down 
from 7 subjects (41.2%) to 4 subjects (23.5%) 
(see table 3).
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Discussion
In baseline characteristic of the study, 
there were no signifi cant diff erences in age, 
sex, education, comorbid, medication and 
body mass index. Th us, all basic factors did 
not infl uence the study results.
One study showed that the albumin was 
not diff erent by sex, unlike HbA1c, which was 
signifi cantly higher in men than in women. 
One study mentioned that the published 
albumin refl ects postprandial hyperglycemia 
and indicates glycemic fl uctuations. Invalid 
albumin levels are associated with HbA1c 
levels. Glycated albumin will be affected 
in conditions that interfere with albumin 
metabolism. Glycated albumin will be lower 
in patients with nephrotic syndrome, severe 
obesity, hyperthyroidism and glucocorticoid 
use. Glycated albumin is higher in patients with 
T able 1 Characteristic Data subject
Characteristic Frequency Therapy group
Frequency 
Control Group  P
Age (years)
Mean     54.12 ± 2.6
 
   53.82 ± 2.8
    
        0.756**
Sex:
- Male (%)
- Female (%)
     7 (41.2%)
   10 (58.8%)
    8 (47.1%)
   9 (52.9%)
        0.734*
Education:
- High School (%)
-  Diploma (%)
- Bachelor (%)
    5 (29.4%)
    7 (41.2%)
    5 (29.4%)
   6 (35.3%)
   6 (35.3%)
   5 (29.4%)
        0.826*
Comorbid:
- Hypertension (%)
- Cardiac (%)
- Post Stroke (%)
- No Comorbid (%)
     4 (23.5%)
     2 (11.8%)
     2 (11.8%)
     9 (52.9%)
   3 (17.6%)
   3 (17.6%)
    2 (11.8%)
  9 (52.9%)
 
      0.910*
Diabetes Medication:
- Metformin (%)
- Insulin (%)
- Insulin and metformin (%)
- No therapy (%)
      8 (47.1%)
      3 (17.6%)
      3 (17.6%)
      3 (17.6%)
   8 (47.1 %)
   3 (17.6%)
   3 (17.6%)
   3 (17.6%)
      0.99*
Another medication :
- Anti hypertension (%)
- Anti coagulant (%)
- Anti dyslipidemia (%)
- Anti hypertension and anti coagulant (%)
- Combination anti hypertension, anti 
coagulant, anti dyslipidemia (%)
- No medication (%)
   3 (17.6%)
   2 (11.8%)
   3 (17.6%)
   0 (0%)
   1 (5.9%)
  8 (47.1%)
2 (11.8%)
2 (11.8%)
3 (17.6%)
1 (5.9%)
1 (5.9%)
8 (47.1%)
       0.812*
Physical exercise :
- Walking (%)
- Treadmill (%) 
- Cycling (%)
- No excersise (%)
  5(29.4%)
  1 (5.9%)
  6 (29.4%)
  6 (35.3%)
  5 (29.4%)
  1 (5.9%)
  5 (29.4%)
  6 (35.3%)
 
      0.99*
BMI (kg/m2)   28.5± 3.46 28.64 ± 3.3       0.886*
Smoking                              4 (23.5%)    5 (29.4%)       0.006*
Creatinin (mg/dl)   0.90 ± 0.20 0.93 ± 0.21        0.7**
Albumin (g/dl)    5.67 ±1.03 5.67 ± 1.02        0.9**
 p < 0.05 was  statistically signifi cant diff erence *t-test  **Mann Whitney test
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High starch fi ber versus low fi ber foods 
has been proven to be suitable for patients 
with type 2 DM. Lifestyle changes with an 
increase in fi ber mean in the included study is 
about 18 g / day; to apply this in one's diet will 
include eating a bowl of high fi ber cereal and 
adding more servings of vegetables a day. Th e 
American Diabetes Association recommends 
consumption of 30-50 grams of fi ber per day in 
patients with type 2 diabetes. Epidemiological 
studies show that increased fi ber intake will 
lower the risk of coronary heart disease.
Research Hallstrom et al.12 showed that 
administration of 7.7 grams of resistant starch 
fi ber, high wheat amylose would lower blood 
glucose and increase insulin. In the study of 
Al Tamimi et al.13 the administration of 20 
grams of resistant starch would lower blood 
glucose levels.
Polysaccharide content in gembili has the 
ability to lower blood glucose by decreasing the 
cirrhosis of the liver and hypothyroidism. In 
the obese group, glycated albumin also showed 
lower levels due to chronic micro-infl ammation 
of cytokines secreted by obese adipose subjects, 
which would increase albumin catabolism and 
shorten the albumin cycle. Glycated albumin is 
also lower than blood glucose in patients with 
smokers, hyperuricemia, hypertriglyceridemia, 
and non-alcoholic fatty liver disease.10,11 In 
this study, the increased levels of glycated 
albumin were increased in the control group; 
this is still possible due to glucose fl uctuations 
or postprandial glucose rise, which was not 
assessed in this study.
Metformin is an oral drug that shows 
a decrease in HbA1c ranging from 0.2% 
-2%. In this study with the change of dietary 
resistant starch was detected 10.97% decreased 
of glycated albumin. Th is opens a possibility 
of resistant starch fi ber to be added for DM 
management strategy in controlling blood 
glucose.6
Table 2 Comparison of body mass index and glycated albumin (%) in control group and 
experimental group 
Variable
Experimental Control  P value
Means (SD) Means (SD)
IMT (kg/m2) Pre
IMT (kg/m2) Post
28.50 ± 3.46
28.54 ± 3.02
  28.64 ±3.33
  28.69 ±2.89
*0.88
*0.81
Glycated albumin (%) Pre
Glycated albumin (%) Post
29.71 ± 22.93
18.73 ± 15.97
  15.1 ± 12.03
  18.13 ± 16.43
**0.667
**0.66
Δ Glycated albumin  -10.97 ± 14.6   3.02 ±7.13 **0.01
p < 0.05 was statistically signifi cant diff erence * t-test; ** Mann Whitney test; Δ pre-post test of glycated albumin
Table 3 Subanalysis comparison of group glycated albumin (%) in control group and 
experimental group 
Variable Pretest p Post test p
Control Experimental Control Experimental
Very good 13 (76.5%) 12 (70.6 %) 0.132 8 (47.1%) 11 (64.7 %) 0.5
Good 1 (5.9 %) 0 2 (11.8%) 2 (11.8 %)
Fair 0 0 0 0
Fail 3 (17.6%) 5 (29.4 %) 7 (41.2 %) 4 (23.5 %)
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absorption of blood glucose in the intestines. 
Non-starch fi bers, which also contain cellulose, 
lignin, and insoluble inulin, will shorten transit 
time in the intestines. In the colon, carbohydrate 
compounds that are not digesting by digestive 
enzymes fermented by bacteria and produce 
major short chain fatty acids such as acetic acid, 
propionic acid and butyric acid. Th e type of 
short-chain fatty acids produced depends on 
the source of food consumed. Short chain fatty 
acids are able to control the body's metabolism, 
which among others was to regulate insulin 
sensitivity, regulate the secretion of hormones in 
the digestive tract and regulate other metabolic 
processes. Th e magnitude of acetate, propionate, 
butyric formation is infl uenced by environmental 
conditions of colon, microbiota type and free 
fatty acid receptor 2 and free fatty acid receptor 
3.14
Conclussion 
In this study it was shown that there was 
a signifi cant improvement of glycated albumin 
in the group receiving dietary supplementation 
based on resistant starch fiber. advanced 
research with randomized and assessed uric 
acid and triglycerides that may interfere with 
albumin glycation and glucose examination 
can improve the accuracy of this research. 
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